A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...

KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

Using acetaminophen during pregnancy does not increase a child's risk of autism, ADHD or intellectual disability, a major new ...

Granules Pharmaceuticals, a wholly-owned subsidiary of Granules India, has received tentative approval from the US Food and ...

Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes to the product’s safety label to reflect research about a possible ...